Gynecologic Oncology Group risk groups for vulvar carcinoma: Improvement in survival in the modern era

Gynecologic Oncology

Volumn 106, Issue 3, 2007, Pages 521-525

  Landrum, Lisa M ^a   Lanneau, Grainger S ^a   Skaggs, Valerie J ^b   Gould, Natalie ^c   Walker, Joan L ^a   McMeekin, D Scott ^a   Gold, Michael A ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c Carilion Gyn Oncology Associates   (United States)

Author keywords

Adjuvant chemo radiation; Prognostic factors; Surgery; Survival; Vulvar carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GROUPS BY AGE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME; VULVA CARCINOMA;

CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; VULVAR NEOPLASMS;

EID: 34548124983     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2007.04.029     Document Type: Article

References (26)

1. Sedlis A., Homesley H., Bundy B.N., Marshall R., Yordan E., Hacker N., et al. Positive groin lymph nodes in superficial squamous cell vulvar cancer. A Gynecologic Oncology Group Study. Am J Obstet Gynecol 156 5 (1987) 1159-1164
2. Homesley H.D., Bundy B.N., Sedlis A., Yordan E., Berek J.S., Jahshan A., et al. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol 49 3 (1993) 279-283
3. Homesley H.D., Bundy B.N., Sedlis A., Yordan E., Berek J.S., Jahshan A., et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 164 4 (1991) 997-1003
4. Basset A. Traitement chirurgical operatoire de l'epithelioma primitive du clitoris. Rev Chir Oncol Radiol ORL Oftalmol Stomatol Oncol (1912) 46546-46570
5. Taussig F.J. Cancer of the vulva. Am J Obstet Gynecol (1940) 40764-40779
6. Way S. Carcinoma of the vulva. Am J Obstet Gynecol (1960) 79692-79697
7. DiSaia P.J., Creasman W.T., and Rich W.M. An alternate approach to early cancer of the vulva. Am J Obstet Gynecol 133 7 (4-1-1979) 825-832
8. Berman M.L., Soper J.T., Creasman W.T., Olt G.T., and DiSaia P.J. Conservative surgical management of superficially invasive stage I vulvar carcinoma. Gynecol Oncol 35 3 (1989) 352-357
9. Siller B.S., Alvarez R.D., Conner W.D., McCullough C.H., Kilgore L.C., Partridge E.E., et al. T2/3 vulva cancer: a case-control study of triple incision versus en bloc radical vulvectomy and inguinal lymphadenectomy. Gynecol Oncol 57 3 (1995) 335-339
10. Hacker N.F., Leuchter R.S., Berek J.S., Castaldo T.W., and Lagasse L.D. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 58 5 (1981) 574-579
11. Burrell M.O., Franklin III E.W., Campion M.J., Crozier M.A., and Stacy D.W. The modified radical vulvectomy with groin dissection: an eight-year experience. Am J Obstet Gynecol 159 3 (1988) 715-722
12. Hacker N.F., Berek J.S., Lagasse L.D., Nieberg R.K., and Leuchter R.S. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet Gynecol 63 2 (1984) 155-162
13. Heaps J.M., Fu Y.S., Montz F.J., Hacker N.F., and Berek J.S. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38 3 (1990) 309-314
14. Stehman F.B., Bundy B.N., Dvoretsky P.M., and Creasman W.T. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 79 4 (1992) 490-497
15. Boronow R.C. Combined therapy as an alternative to exenteration for locally advanced vulvo-vaginal cancer: rationale and results. Cancer 49 6 (3-15-1982) 1085-1091
16. Moore D.H., Thomas G.M., Montana G.S., Saxer A., Gallup D.G., and Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int J Radiat Oncol Biol Phys 42 1 (8-1-1998) 79-85
17. Montana G.S., Thomas G.M., Moore D.H., Saxer A., Mangan C.E., Lentz S.S., et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 48 4 (11-1-2000) 1007-1013
18. Homesley H.D., Bundy B.N., Sedlis A., and Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68 6 (1986) 733-740
19. Stehman F.B., Bundy B.N., Ball H., and Clarke-Pearson D.L. Sites of failure and times to failure in carcinoma of the vulva treated conservatively: a Gynecologic Oncology Group study. Am J Obstet Gynecol 174 4 (1996) 1128-1132
20. Podratz K.C., Symmonds R.E., Taylor W.F., and Williams T.J. Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 61 1 (1983) 63-74
21. Shanbour K.A., Mannel R.S., Morris P.C., Yadack A., and Walker J.L. Comparison of clinical versus surgical staging systems in vulvar cancer. Obstet Gynecol 80 6 (1992) 927-930
22. Judson P.L., Habermann E.B., Baxter N.N., Durham S.B., and Virnig B.A. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 107 5 (2006) 1018-1022
23. Messing M.J., and Gallup D.G. Carcinoma of the vulva in young women. Obstet Gynecol 86 1 (1995) 51-54
24. Jones R.W., Baranyai J., and Stables S. Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia. Obstet Gynecol 90 3 (1997) 448-452
25. Carter J., Carlson J., Fowler J., Hartenbach E., Adcock L., Carson L., et al. Invasive vulvar tumors in young women-a disease of the immunosuppressed?. Gynecol Oncol 51 3 (1993) 307-310
26. Rutledge F.N., Mitchell M.F., Munsell M.F., Atkinson E.N., Bass S., McGuffee V., et al. Prognostic indicators for invasive carcinoma of the vulva. Gynecol Oncol 42 3 (1991) 239-244